检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:谭燕 张健[1] Tan Yan;Zhang Jian(Department of Neurology,the First Affiliated Hospital of Sun Yat-sen University,Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases,National Key Clinical Specialty and Key Discipline of Neurology,Guangzhou,510080,China)
机构地区:[1]中山大学附属第一医院神经内科,广东省重大神经疾病诊治研究重点实验室,国家临床重点专科和国家重点学科,广州510080
出 处:《国际脑血管病杂志》2021年第2期142-147,共6页International Journal of Cerebrovascular Diseases
基 金:国家重点研发计划项目(2017YFC1307501);广东省自然科学基金(2017A030313575);广东省自然科学基金(2017A030310523);华南神经疾病早期干预及功能修复研究国际合作基地(2015B050501003)
摘 要:血脂异常是卒中高危因素,降低低密度脂蛋白胆固醇(low-density lipoprotein chesterol,LDL-C)水平可降低缺血性卒中发病风险。他汀类药物和PCSK9抑制剂均可有效降低LDL-C水平,但有些患者不能耐受他汀类药物,而PCSK9抑制剂则价格昂贵。动物实验显示,依折麦布可通过激活腺苷酸活化蛋白激酶(AMP-activated protein kinase,AMPK)信号通路减轻氧化应激和内质网应激反应,抑制细胞凋亡,增加自噬,从而保护神经组织。临床研究表明,依折麦布可在他汀类药物治疗基础上进一步降低LDL-C水平,降低急性冠状动脉综合征患者的缺血性卒中风险,且没有明显不良反应。但是,对于年龄≥75岁、LDL-C升高且没有冠心病的老年人,依折麦布则不能降低卒中发生率。目前,依折麦布用于缺血性卒中二级预防的相关研究较少,其作用尚需大样本随机对照试验进一步证实。Dyslipidemia is a risk factor for stroke,and reducing low-density lipoprotein cholesterol(LDL-C)levels can decrease the risk of ischemic stroke.Both statins and PCSK9 inhibitors can effectively reduce LDL-C levels,but some patients cannot tolerate statins,and PCSK9 inhibitors are expensive.Animal experiments have shown that ezetimibe can reduce oxidative stress and endoplasmic reticulum stress response,inhibit cell apoptosis,increase autophagy,and protect nerve tissue by activating AMP activated protein kinase(AMPK)signaling pathway.Clinical studies have shown that ezetimibe can further reduce LDL-C levels on the basis of statin therapy,and reduce the risk of ischemic stroke in patients with acute coronary syndromes,and there is no obvious adverse reaction.However,ezetimibe cannot reduce the incidence of stroke in elderly people who are≥75 years old,have elevated LDL-C and do not have coronary heart disease.At present,there are few studies on the use of ezetimibe for secondary prevention of ischemic stroke,and its effect needs to be further confirmed by large randomized controlled trials.
关 键 词:卒中 脑缺血 依折麦布 降血脂药 抗胆固醇血症药
分 类 号:R743.3[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.21.126.72